From manufacturing to retail distribution, the pharmaceutical industry is heavily regulated. These regulations come at both the federal and state level, with requirements often varying considerably from state-to-state.
Operating without a license — or with an expired one — can lead to steep fines and criminal prosecution. Avoid these serious consequences and navigate the landscape with ease by tuning into this on-demand webinar.
Healthcare and Pharmaceutical Industry Business Licensing
Our experts cover an end-to-end view of business license compliance in the human drug industry. The four key areas covered are: drug manufacturing, import/export, wholesale distribution, and retail pharmacies. Within these topics, you will learn about aspects such as: federal laws when importing drugs from other countries, the role of 3PL providers in wholesale distribution, and the differences between resident and nonresident licensing for retail pharmacies.
At the end of the webinar is a fireside chat where our experts discuss the Drug Supply Chain Security Act.
Topics covered:
Who should join:
Your expert guides:
Hans Howk — Manager, Content Management
Hans provides internal support to key members of the Business Licensing Team, assisting with understanding industry nuances, searching and synthesizing statutes and regulations relating to business law, and liaising with licensing representatives and regulatory bodies at all levels of government. Hans oversees the company knowledgebase of business license regulations and filing processes across all industries. Read more about Hans.
David Yount — Vice President & Head of Business Licenses
After the successful acquisition of LicenseLogix by Wolters Kluwer in 2021, David Yount joined CT Corporation as VP and Head of Business Licenses. Today he continues to run the business licensing arm of CT Corporation, expanding the licensing team and services offered by CT. Yount, a licensed attorney, launched LicenseLogix in 2011 and released the web-based license portal, CLiC®, in April of 2012.
